Trial Condition(s):

Arterial hypertension

Survey to assess why people are not responding to treatment in Hypertension

Bayer Identifier:

14675

ClinicalTrials.gov Identifier:

NCT01071681

EudraCT Number:

Not Available

Study Completed

Trial Purpose

This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients

Inclusion Criteria
:

 - Men or women over 18
 - Hypertensive patients
 - Uncontrolled hypertension (blood pressure >/=140/90 mmHg on the day of consultation or >/=130/80 mmHg in diabetic patients or in patients suffering from kidney failure, or in elderly patients with a systolic blood pressure >/=150 mmHg (in the absence of orthostatic hypotension)
 - Patients treated with a combination, fixed or not, of Renin-Angiotensin System Blocker (RASB) + Hydrochlorothiazide (HCTZ)
 - Patients examined in common medical care practice, whatever the reason for consultation  
 - Patients informed of the study
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
1589
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many Locations, France

Status
Completed
 

Trial Design